Trastuzumab resistance siRNA screen identifies PPM1H.

Slides:



Advertisements
Similar presentations
Volume 11, Issue 4, Pages (April 2007)
Advertisements

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
ETV1 positively regulates KIT expression through direct binding to KIT enhancers in human GIST cells and forms a positive feedback circuit in GIST oncogenesis.
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
by Anupama Narla, Shilpee Dutt, J
A B 20% O2 5% O2 C 5% O2 + NAC DAPI gH2AX pLKO.1 GFP-SOD1 S 0.1Gy
 Design and use of a high-throughput screen to identify tumor cell-induced gene activation events in Salmonella.  Design and use of a high-throughput screen.
Pioglitazone inhibits aromatase expression in human preadipocytes.
Identification of TLOC1 and SKIL as tumor driver genes in 3q26.
A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.
Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.
Absence of ARMS-associated chromosomal translocation.
XIST regulated miR-29c by directly targetting in TMZ-resistant glioma cells XIST regulated miR-29c by directly targetting in TMZ-resistant glioma cells.
An siRNA screen identifies BER pathway members as sensitizers to temozolomide (TMZ) in pediatric GBM. A and B, SJG2 and KNS42 cells were transfected with.
Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK inhibitors. Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK.
Volume 14, Issue 3, Pages (January 2016)
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
TYK2 is required for the survival of T-ALL cells.
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
Knockdown efficiency of different shRNAs.
MMAP is required for spindle dynamics regulation.
The effects of KY19382 on chondrocyte proliferation and differentiation. The effects of KY19382 on chondrocyte proliferation and differentiation. (A) ATDC5.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation. Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation.
PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. PTK6 downregulation suppresses SNAIL and increases E-cadherin expression. A,
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Wild-type NSD3 is required for the blockade of differentiation in BRD4–NUT-expressing NMC cells. Wild-type NSD3 is required for the blockade of differentiation.
Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro. Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro.
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Effect of siRNA transfection on colony formation by Renca cells.
Fig. 6 Metarrestin treatment reduces pre-RNA synthesis and Pol I occupancy at rDNA without changing rDNA chromatin states. Metarrestin treatment reduces.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.
SiRNA screening identifies genes required for the viability of Pim1-ovexpressing prostate cells. siRNA screening identifies genes required for the viability.
Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis. Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis.
PELP1 regulates the expression and activities of MMPs in ER-negative cells. PELP1 regulates the expression and activities of MMPs in ER-negative cells.
Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.
A, top, representative Western blot for Ku70 in MCF7 cell extracts following siRNA knockdown of Ku70, compared with siRNA control. A, top, representative.
Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases. Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases.
Knockdown of PKM2 suppressed TPA-induced skin cell transformation.
High-throughput siRNA screening results and corresponding patient gene expression data for PP2A subunits. High-throughput siRNA screening results and corresponding.
A and B, mRNA expression relative to ERα (in%) for ZNF423 (A) and BRCA1 (B) for LCLs of known genotypes for variant (V) and WT chromosome 16 ZNF423 SNPs.
Gain-of-function conferred by RNF31 SNPs
Specific DNA methylation and expression signatures associated with binding of E2A–PBX1 fusion protein. Specific DNA methylation and expression signatures.
Model of ATM-MPG–mediated therapeutic resistance in pGBM.
Inactivation of human TRAC and CD52 genes by TALENs
Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,
Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.
LRH-1 controls cell proliferation in antiestrogen-sensitive and antiestrogen-resistant breast cancer. LRH-1 controls cell proliferation in antiestrogen-sensitive.
CLIC1 supports invadopodia formation in vitro and metastasis in vivo.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
The effects of HDAC2 knockdown on cell-cycle proteins.
Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.
Adhesion to fibronectin protects Mcl-1 knockdown cells from apoptosis.
Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and.
BUB1B is validated as a candidate glioblastoma-lethal gene in vitro.
CCR5 enhances both HDR and SSA DNA repair.
DEAR1 blocks TGF-β–induced anoikis resistance, and TGF-β and SMAD3 signal transduction. DEAR1 blocks TGF-β–induced anoikis resistance, and TGF-β and SMAD3.
Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.
siRNA screen validation.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
RRP1B interacts with TRIM28 and HP1α at regions associated with H3K9me3 and decreased gene expression. RRP1B interacts with TRIM28 and HP1α at regions.
H3K36me3 is not essential for LEDGF and MLL target gene occupancy.
FGF19 amplification in liver cancer cell lines is associated with response to NVP-BGJ398. FGF19 amplification in liver cancer cell lines is associated.
Driver pathways and key genes in OSCC
Hoxa9 is partly required for Twist1-induced migration, invasion, anoikis resistance, and soft agar tumorigenicity of Myc-CaP cells. Hoxa9 is partly required.
Wnt5A and ROR2 contribute to intrinsic resistance to BRAF inhibitors.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
Fig. 1 Cellular PFAS negatively regulates RTA-dependent transcriptional activation. Cellular PFAS negatively regulates RTA-dependent transcriptional activation.
Presentation transcript:

Trastuzumab resistance siRNA screen identifies PPM1H. Trastuzumab resistance siRNA screen identifies PPM1H. A, knockdown of the top 7 screen hits in an assay of cell proliferation in BT474M1 cells with and without trastuzumab (mean ± SEM). % knockdown by qRT-PCR is noted for each gene. B, PPM1H or control shRNA was transfected with a GFP vector or a GFP-PPM1H-SM vector harboring silent mutations in the shRNA binding region. GFP-positive cells were quantified (mean ± SEM). C, PPM1H knockdown with and without trastuzumab treatment was tested in 3D culture using a doxycycline-inducible BT474M1-PPM1H shRNA cell line. Data with a negative control shLacZ cell line are shown in Supplemenary Fig. 3A. Colony area is represented by box and whisker plot (whiskers represent 5th and 95th percentiles). Si Tuen Lee-Hoeflich et al. Cancer Discovery 2011;1:326-337 ©2011 by American Association for Cancer Research